23.05 USD
+0.71
3.18%
Updated Apr 1, 3:41 PM EDT
1 day
3.18%
5 days
7.01%
1 month
4.77%
3 months
30.01%
6 months
42.46%
Year to date
30.01%
1 year
-36.87%
5 years
31.49%
10 years
44.60%
0
Funds holding %
of 7,398 funds
0
Analysts bullish %
of 4 analysts

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

179% more call options, than puts

Call options by funds: $8.57M | Put options by funds: $3.07M

1.79% more ownership

Funds ownership: 96.05% [Q3] → 97.83% (+1.79%) [Q4]

2% more capital invested

Capital invested by funds: $1.41B [Q3] → $1.44B (+$26.5M) [Q4]

7% less funds holding

Funds holding: 283 [Q3] → 262 (-21) [Q4]

22% less repeat investments, than reductions

Existing positions increased: 76 | Existing positions reduced: 97

25% less first-time investments, than exits

New positions opened: 54 | Existing positions closed: 72

67% less funds holding in top 10

Funds holding in top 10: 3 [Q3] → 1 (-2) [Q4]

Research analyst outlook

4 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$23
0%
upside
Avg. target
$25
7%
upside
High target
$28
21%
upside

4 analyst ratings

positive
50%
neutral
50%
negative
0%
BTIG
David Larsen
31% 1-year accuracy
5 / 16 met price target
21%upside
$28
Buy
Upgraded
31 Mar 2025
Canaccord Genuity
Richard Close
41% 1-year accuracy
11 / 27 met price target
0%downside
$23
Hold
Maintained
28 Feb 2025
B of A Securities
Michael Cherny
68% 1-year accuracy
19 / 28 met price target
8%upside
$25
Buy
Maintained
11 Feb 2025
JP Morgan
Anne Samuel
51% 1-year accuracy
18 / 35 met price target
0%downside
$23
Neutral
Maintained
28 Jan 2025

Financial journalist opinion

Based on 4 articles about PGNY published over the past 30 days

Neutral
GlobeNewsWire
1 day ago
Progyny Expands Maternal Health Support with Addition of Doula Services
Available to employers and health plans, the in-person and virtual doula care services can close more care gaps and improve health outcomes Available to employers and health plans, the in-person and virtual doula care services can close more care gaps and improve health outcomes
Progyny Expands Maternal Health Support with Addition of Doula Services
Neutral
GlobeNewsWire
3 weeks ago
Progyny Expands Family Building Solutions with New Parent and Child Well-being Offering
The in-demand program provides high-touch, holistic support for working parents and caregivers, addressing return-to-work challenges, emotional health support, and benefit navigation The in-demand program provides high-touch, holistic support for working parents and caregivers, addressing return-to-work challenges, emotional health support, and benefit navigation
Progyny Expands Family Building Solutions with New Parent and Child Well-being Offering
Neutral
GlobeNewsWire
3 weeks ago
Progyny, Inc. to Participate in Upcoming Investor Conferences
NEW YORK, March 07, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women's health benefits solution, today announced it expects to participate in several upcoming investor conferences. Progyny executives will participate in a fireside chat at the Leerink Partners Global Healthcare Conference in Miami, FL on Monday, March 10, 2025, at 11:20 a.m. Eastern Time. The executives will then be participating in meetings at the Barclays 27th Annual Global Healthcare Conference in Miami, FL on Tuesday, March 11, 2025.
Progyny, Inc. to Participate in Upcoming Investor Conferences
Positive
Schwab Network
4 weeks ago
PGNY CEO on "Well-Positioned" Sales Year & Expanding Footprint
Pete Anevski, CEO of Progyny (PGNY), discusses his company's latest earnings and how it's poised for a "well-positioned" year. He notes general healthcare headwinds for the women's health company, though he expects Progyny to find new clients and retain current customers.
PGNY CEO on "Well-Positioned" Sales Year & Expanding Footprint
Positive
The Motley Fool
1 month ago
Progyny Tops EPS Forecast, Eyes Growth
Progyny (PGNY -1.68%), a pioneer in fertility benefits management, released its earnings for the fourth quarter on Feb. 27. The standout points were its impressive revenue and adjusted earnings per share (EPS) results, both of which surpassed analysts' consensus predictions.
Progyny Tops EPS Forecast, Eyes Growth
Neutral
Seeking Alpha
1 month ago
Progyny, Inc. (PGNY) Q4 2024 Earnings Call Transcript
Progyny, Inc. (NASDAQ:PGNY ) Q4 2024 Earnings Conference Call February 27, 2025 4:45 PM ET Company Participants James Hart - Investor Relations Pete Anevski - Chief Executive Officer Mark Livingston - Chief Financial Officer Michael Sturmer - President Conference Call Participants Anne Samuel - JPMorgan Michael Cherny - Leerink Partners John Pinney - Canaccord Genuity Scott Schoenhaus - KeyBanc Jailendra Singh - Truist Securities Allen Lutz - Bank of America Sarah James - Cantor Constantine Davides - Citizens JMP Jenny Shen - BTIG Operator Good day, ladies and gentlemen. Welcome to the Progyny, Inc. Fourth Quarter Earnings Conference Call.
Progyny, Inc. (PGNY) Q4 2024 Earnings Call Transcript
Neutral
GlobeNewsWire
1 month ago
Progyny, Inc. Announces Fourth Quarter 2024 Results
Reports Quarterly Revenue of $298.4 Million, Reflecting 10.6% GrowthGenerated $52.2 Million of Quarterly Operating Cash FlowIssues Financial Guidance for 2025, Reflecting Tenth Consecutive Year of Revenue Growth
Progyny, Inc. Announces Fourth Quarter 2024 Results
Positive
Zacks Investment Research
1 month ago
Progyny (PGNY) Reports Next Week: Wall Street Expects Earnings Growth
Progyny (PGNY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Progyny (PGNY) Reports Next Week: Wall Street Expects Earnings Growth
Neutral
GlobeNewsWire
1 month ago
Progyny, Inc. Announces Details for Its Fourth Quarter and Full Year 2024 Results Report
NEW YORK, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women's health benefits solution, will report its financial results for the quarterly period and full year ended December 31, 2024, after the close of the market on Thursday, February 27, 2025. The company will host a conference call at 4:45 p.m.
Progyny, Inc. Announces Details for Its Fourth Quarter and Full Year 2024 Results Report
Neutral
GlobeNewsWire
1 month ago
Kuehn Law Encourages Investors of Progyny, Inc. to Contact Law Firm
NEW YORK, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Progyny, Inc. (NASDAQ: PGNY) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms.
Kuehn Law Encourages Investors of Progyny, Inc. to Contact Law Firm
Charts implemented using Lightweight Charts™